Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.
Is it a sign of a good healthcare system when millions of people turn to a hallucinating robot for help? Reading time 2 minutes OpenAI just released a report about healthcare drawn from anonymized ...
The NFL has announced its International Player Pathway (IPP) program Class of 2026, featuring 13 athletes representing 10 nations around the world. Established in 2017, the IPP program identifies ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
1 Laboratory Molecular Immunopathology, Postgraduate Program in Internal Medicine and Health Sciences, Federal University of Paraná (UFPR), Curitiba, PR, Brazil 2 Laboratory Human Molecular Genetics, ...
OWENS CROSS ROAD, Ala. (WHNT) — The Owens Cross Roads City Council has voted to pursue legal action against a mental health facility operating in the city. During a special-called meeting on Thursday, ...
– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...
SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Bye Sweet Carole is an indie puzzle-platformer game that follows Lana Benton as she searches for her missing best friend, Carole Simmons. This exquisite, completely hand-drawn animated game is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results